Using biofilms as initial inocula in animal models of biofilm-related infections

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 4, 2012, Pages 1163-1169

  Williams, Dustin L ^a,b,c   Costerton, J William ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Utah   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

animal model; biofilm; future research; initial inocula; planktonic

Indexed keywords

ANIMAL MODEL; ANIMAL STUDIES; BACTERIAL CELLS; BATCH CULTURE; CLINICAL INFECTION; IMPLANTED DEVICE; INITIAL INOCULUMS; INOCULA; PLANKTONIC;

BATCH CELL CULTURE; TISSUE;

BIOFILMS;

ANTIBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; BIOFILM; DEVICE INFECTION; DISEASE SEVERITY; INOCULATION; MATERIAL COATING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPEN FRACTURE; REVIEW;

ANIMALS; BACTERIA; BATCH CELL CULTURE TECHNIQUES; BIOCOMPATIBLE MATERIALS; BIOFILMS; DISEASE MODELS, ANIMAL; HUMANS; PLANKTON; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS;

EID: 84859577709     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31979     Document Type: Review

References (82)

1. Buret A, Ward KH, Olson ME, Costerton JW,. An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces. J Biomed Mater Res 1991; 25: 865-874.
2. Cirioni O, Mocchegiani F, Ghiselli R, Silvestri C, Gabrielli E, Marchionni E, Orlando F, Nicolini D, Risaliti A, Giacometti A,. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection. Eur J Vasc Endovasc Surg 2010; 40: 817-822.
3. Lambe DWJ, Ferguson KP, Mayberry-Carson KJ, Tober-Meyer B, Costerton JW,. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthopaedics Related Res 1991; 266: 285-294.
4. Darouiche RO, Farmer J, Chaput C, Mansouri M, Saleh G, Landon GC,. Anti-infective efficacy of antiseptic-coated intramedullary nails. J Bone Joint Surg 1998; 80: 1336-1340.
5. Darouiche RO, Mansouri MD,. Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo. J Infect 2005; 50: 206-209.
6. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S,. Antimicrobial and antibiofilm efficacy of triclosan and dispersin B combination. J Antimicrobial Chemotherapy 2009; 64: 88-93.
7. Darouiche RO, Mansouri MD, Zakarevicz D, AlSharif A, Landon GC,. In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg 2007; 89: 792-797.
8. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM,. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repar Regenerat 2008; 16: 23-29.
9. Dohar JE, Hebda PA, Veeh R, Awad M, Costerton JW, Hayes J, Ehrlich GD,. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media. Laryngoscope 2005; 115: 1469-1472.
10. Elasri MO, Thomas JR, Skinner RA, Blevins JS, Beenken KE, Nelson CL, Smeltzer MS,. Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone 2002; 30: 275-280.
11. Fernandez-Hidalgo N, Gavalda J, Almirante B, Martin M-T, Onrubia PL, Gomis X, Pahissa A,. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibitoic-Locl technique for Staphylococcus aureus catheter-related infection. J Antimicrobial Chemotherapy 2010; 65: 525-530.
12. Hansen LK, Berg K, Johnson D, Sanders M, Citron M,. Efficacy of local rifampin/minocycline delivery (AIGISRXA®) to eliminate biofilm formation on implanted pacing devices in a rabbit model. Int J Artificial Organs 2010; 33: 627-635.
13. Hart E, Azzopardi K, Taing H, Graichen F, Jeffery J, Mayadunne R, Wickramaratna M, O'Shea M, Nijagal B, Watkinson R, O'Leary S, Finnin B, Tait R, Robins-Browne R,. Efficacy of antimicrobial polymer coatings in an animal model of bacterial infection associated with foreign body implants. J Antimicrobial Chemotherapy 2010; 65: 974-980.
14. Keeling WB, Myers AR, Stone PA, Heller L, Widen R, Back MR, Johnson BL, Bandyk DF, Shames ML,. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections. J Surg Res 2009; 157: 223-226.
15. Li B, Brown KV, Wenke JC, Guelcher SA,. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J Control Release 2010; 145: 221-230.
16. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP, Raschke M,. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 2003; 32: 521-531.
17. Mayberry-Carson KJ, Tober-Meyer B, Smith JK, D.W. Lambe J, Costerton JW,. Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococus aureus. Infect Immunity 1984; 43: 825-833.
18. Reid SD, Hong W, Dew KE, Winn DR, Pang B, Watt J, Glover DT, Hollingshead SK, Swords WE,. Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas. J Infect Dis 2009; 199: 786-794.
19. Zou G-Y, Shen H, Jiang Y, Zhang X-L,. Synergistic effect of a novel focal hyperthermia on the efficacy of rifampin in staphylococcal experimental foreign-body infection. J Int Med Res 2009; 37: 1115-1126.
20. Brin YS, Golenser J, Mizrahi B, Maoz G, Domb AJ, Peddada S, Tuvia S, Nyska A, Nyska M,. Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release 2008; 131: 121-127.
21. Xie Z, Liu X, Jia W, Zhang C, Huang W, Wang J,. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. J Control Release 2009; 139: 118-126.
22. Krasko MY, Golenser J, Nyska A, Nyska M, Brin YS, Domb AJ,. Gentamicin extended release from an injectable polymeric implant. J Control Release 2007; 117: 90-96.
23. Williams D, Bloebaum R, Petti CA,. Characterization of Staphylococcus aureus strains in a rabbit model of osseointegrated pin infections. J Biomed Mater Res A 2008; 85: 366-70.
24. Chou TGR, Petti CA, Szakacs J, Bloebaum RD,. Evaluating antimicrobials and implant materials for infection prevention around transcutaneous osseointegrated implants in a rabbit model. J Biomed Mater Res A 2010; 92: 942-952.
25. ZoBell CE,. The effect of solid surfaces upon bacterial activity. J Bacteriol 1943; 46: 39-56.
26. Costerton JW,. The Predominance of biofilms in natural and engineered ecosystems. In:, Costerton JW, editor. The biofilm primer. Heidelberg: Springer; 2007. pp 5-13.
27. Costerton JW, Geesey GG, Cheng KJ,. How bacteria stick. Sci Am 1978; 238: 86-95.
28. Lawrence JR, Korber DR, Hoyle BD, Costerton JW, Caldwell DE,. Optical sectioning of microbial biofilms. J Bacteriol 1991; 173: 6558-6567.
29. Geesey GG, Richardson WT, Yeomans HG, Irvin RT, Costerton JW,. Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol 1977; 23: 1733-1736.
30. James GA, Swogger E, Wolcott R, Pulcini Ed, Secor P, Sestrich J, Costerton JW, Stewart PS,. Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
31. Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR,. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci USA 2009; 106: 16393-16399.
32. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD,. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008; 6: 43.
33. Gristina AG, Costerton JW,. Bacteria-laden biofilms: A hazard to orthopedic prostheses. Infect Surg 1984; 3: 655-662.
34. Marrie T, Nelligan J, Costerton J,. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 1982; 66: 1339-1341.
35. Wimpenny J, Manz W, Szewzyk U,. Heterogeneity in biofilms. FEMS Microbiol Rev 2000; 24: 661-671.
36. Costerton JW,. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001; 9: 50-52.
37. Gustilo RB, Mendoza RM, Williams DN,. Problems in the management of type III (severe) open fractures: A new classification of type III open fractures. J Trauma 1984; 24: 742-746.
38. Gustilo RB, Merkow RL, Templeman D,. The management of open fractures. J Bone Joint Surg 1990; 72: 299-304.
39. Zalazras CG, Marcus RE, Levin S, Patzakis MJ,. Management of open fractures and subsequent complications. J Bone Joint Surg 2007; 89: 884-895.
40. Johnson EN, Burns TC, Hayada RA, Hospenthal DR, Murray CK,. Infectious complications of open type III tibial fracture amon combat casualties. Clinical Infect Dis 2007; 45: 409-415.
41. Lambert EW, Simpson RB, Marzouk A, Unger DV,. Orthopaedic injuries among survivors of USS cole attack. J Orthopaedic Trauma 2003; 17: 436-441.
42. Bakken LR,. Separation and purification of bacteria from soil. Appl Environ Microbiol 1985; 49: 1482-1487.
43. Torsvik V, Goksoyr J, Daae FL,. High diversity in DNA of soil bacteria. Appl Environment Microbiol 1990; 56: 782-787.
44. Cerca N, Jefferson KK, Oliviera R, Pier GB, Azeredo J,. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immunity 2006; 74: 4849-4855.
45. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK,. The Exopolysacharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-γ-mediated macrophage killing. J Immunol 2005; 175: 7512-7518.
46. Donlan RM,. Biofilms Associated with medical devices and implants. In:, Jass J, Surman S, Walker J, editors. Medical Biofilms: Detection, Prevention, and Control; Chichester West Sussex, England: John Wiley and Sons Ltd; 2003. pp 29-96.
47. Gaudin A, Valle GAD, Hamel A, Mabecque VL, Miegeville A-F, Potel G, Caillon J, Jacqueline C,. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit. Lett Appl Microbiol 2011; 52: 253-257.
48. Nickel JC, Ruseska I, Wright JB, Costerton JW,. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrobial Agents Chemotherapy 1985; 27: 619-624.
49. Melchior MB, Fink-Gremmels J, Gaastra W,. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture. J Veterinary Med Part B 2006; 53: 326-332.
50. Ceri H, Olson ME, Morck DW, Storey DG,. Minimal biofilm eradication concentration (MBEC) assay: Susceptibility testing for biofilms. In:, Pace JL, Rupp ME, Finch RG, editors. Biofilms, Infection, and Antimicrobial Therapy. Boca Raton: CRC Press; 2006. pp 257-269.
51. Costerton JW,. The microbiology of the healthy human body. In:, Costerton JW, editor. The Biofilm Primer. Heidelberg: Springer; 2007. pp 107-128.
52. Brandt C, Hott U, Sohr D, Daschner F, Gastmeier P, Ruden H,. Operating room ventilation with laminar airflow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Annals Surg 2008; 248: 695-700.
53. Sponseller PO, Shah SA, Abel MF, Newton PO, Letko L, Marks M,. Infection rate after spine surgery in cerebral palsy is high and impairs results. Clin Orthopaedics Related Res 2010; 468: 711-716.
54. Kaltsas DS,. Infection after total hip arthroplasty. Annals Royal College Surgeons England 2004; 86: 267-271.
55. Tate A, Yazdany T, Bhatia N,. The use of infection prevention practices in female pelvic medicine and reconstructive surgery. Current Opin Obstetrics Gynecol 2010; 22: 408-413.
56. Pozo JLD, Patel R,. Infection associated with prosthetic joints. New England J Med 2009; 361: 787-794.
57. Murray CK,. Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan. J Trauma 2008; 64: S232-S238.
58. Owens BD, John F,., Kragh J, Macaitis J, Svoboda SJ, Wenke JC,. Characterization of extremity wounds in operation iraqi freedom and operation enduring freedom. J Orthopaedic Trauma 2007; 21: 254-257.
59. Zimmerli W,. Prosthetic-joint-associated infections. Best Practice Res Clin Rheumatol 2006; 20: 1045-1063.
60. Thomas JG, Nakaishi LA,. Managing the complexity of a dynamic biofilm. J Am Dental Assoc 2006; 137: 10S-15S.
61. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, Wolfsberg TG, Turner ML, Segre JA,. A diversity profile of the human skin microbiota. Genome Res 2008; 18: 1043-1050.
62. Kloos WE, Musselwhite MS,. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 1975; 30: 381-395.
63. Guarner F, Malagelada J-R,. Gut flora in health and disease. Lancet 2003; 361: 512-519.
64. Simon GL, Gorbach SL,. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174-193.
65. Stephen AM, Cummings JH,. The microbial contribution to human faecal mass. J Med Microbiol 1980; 13: 45-56.
66. Fry DE, Fry RV,. Surgical site infection: The host factor. AORN J 2007; 86: 801-814.
67. Hendley JO, Ashe KM,. Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneium of human skin. Antimicrobial Agents Chemotherapy 1991; 35: 627-631.
68. Edwards R, Harding KG,. Bacteria and wound healing. Curr Opin Infect Dis 2004; 17: 91-96.
69. Robson MC, Heggers JP,. Bacterial quantification of open wounds. Military Med 1969; 134: 19-24.
70. Krizek TJ, Robson MC, Kho E,. Bacterial growth and skin graft survival. Surg Forum 1967; 18: 518.
71. Murphy RC, Robson MC, Heggers JP, Kadowaki M,. The effect of microbial contamination on musculocutaneous and random flaps. J Surg Res 1986; 41: 75-80.
72. 5 bacterial growth guideline: Reassessing its clinical relevance in wound healing. Ostomy Wound Manage 2003; 49: 44-53.
73. Wolcott RD, Rumbaugh KP, James G, Schultz G, Phillips P, Yang Q, Watters C, Stewart PS, Dowd SE,. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care 2010; 19: 320-328.
74. Connell JL, Wessel AK, Parsek MR, Ellington AD, Whiteley M, Shear JB,. Probing prokaryotic social behaviors with bacterial "lobster traps". mBio 2010; 1: e00202-00210.
75. Williams DL, Haymond BS, Bloebaum RD,. Use of delrin plastic in a modified CDC biofilm reactor. Res J Microbiol 2011; 6: 425-429.
76. Williams DL, Woodbury KL, Haymond BS, Parker AE, Bloebaum RD,. A modified CDC biofilm reactor to produce mature biofilms on the surface of PEEK membranes for an in vivo animal model application. Curr Microbiol 2011; 62: 1657-1663.
77. Serralta VW, Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM,. Lifestyles of bacteria in wounds: Presence of biofilms? Wounds 2001; 13: 29-34.
78. Mertz PM,. Cutaneous biofilms: Friend or foe? Wounds 2003; 15: 129-132.
79. Percival SL, Bowler PG,. Biofilms and their potential role in wound healing. Wounds 2004; 16: 234-240.
80. James G, Swogger E, deLancey-Pulcini E,. Biofilms in chronic wounds. In:, Costerton JW, editor. The Role of Biofilms in Device-Related Infections. Heidelberg: Springer; 2009. pp 11-14.
81. Okuda K, Ishihara K, Nakagawa T, Hirayama A, Inayama Y, Okuda K,. Detection of Treponema denticola in atherosclerotic lesions. J Clin Microbiol 2001; 39: 1114-1117.
82. Chiu B,. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999; 138 (Part 2): S534-S536.